Condition
Recreational Drug Use
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (3)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06587139Not ApplicableCompletedPrimary
Evaluation of Teen Connection Project for Trans and Gender Minority Youth
NCT05031832CompletedPrimary
Chemsex Engagement and HIV Biomedical Prevention in MSM
NCT05567354Phase 1CompletedPrimary
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
NCT05571345Phase 1CompletedPrimary
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
NCT03286218Phase 1CompletedPrimary
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
Showing all 5 trials